HopeStage
Back to all studies
Active Not RecruitingNCT05870111

Citicoline or placebo and brain and immune measures in teens who drink alcohol

About this title

Citicoline in Youth Alcohol Use Disorder

Read the official source — NCT05870111
Medication studyAges 16–22United StatesAddiction
The study in practice

Understand this study

Who could participate?

Listed age limits: 16 years to 22 years.

Listed locations
CharlestonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: October 1, 2024
Recruitment status
Active Not Recruiting
Enrollment listed in the registry
56
Sponsor
Medical University of South Carolina
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 16 Years to 22 Years
Official registry ID
NCT05870111
Official title
Show the full official title

Neurobehavioral and Immune Effects of Citicoline in Youth Alcohol Use Disorder

Recruitment & locations

Not recruiting

Charleston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Medical University of South Carolina, a university.

Does this study involve medication?

Yes. The study involves medication, including Citicoline (cytidine diphosphate-choline) and Placebo oral capsule.

Who can participate?

Listed age limits: 16 years to 22 years.

Is this study still recruiting?

The registry lists this study as active, but no longer recruiting.

Want to explore more studies?

Explore studies